DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Ultragenyx, GeneTx Bio Report First Patient Dosed In KIK-AS Study Of GTX-102 For Angelman Syndrome

Benzinga · 03/16/2020 12:42